Mirthe Muilwijk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mirthe Muilwijk has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
- Irene G. M. van Valkengoed
Amsterdam UMC, Universiteit van Amsterdam
12 shared publications Karien Stronks
Amsterdam UMC, Dept. of Public and Occupational Health, University of Amsterdam, Amsterdam, the Netherlands
7 shared publications- Joline Wilhelma Johanna Beulens
Amsterdam UMC
5 shared publications Anuradhani Kasturiratne
Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
4 shared publicationsMarie Loh
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
4 shared publicationsMarjo-Riitta Jarvelin
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary’s Campus, Norfolk Place, London, UK
4 shared publications
Latest Publications
- Open Access
- 14 August 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (8) , e0354964
An ecosyndemic framework for understanding obesity: Spatial clustering of health, environmental and socioeconomic disadvantage in the Netherlands
Introduction: Obesity and related health conditions are unevenly distributed across neighborhoods, often co-occuring with multiple health challenges and socioeconomic disadvantages. Using an ecosyndemic framework, which integrates ecological and social dimensions that contribute to the clustering of health problems, this study examines how adverse obesity-related health outcomes spatially cluster in relation to obesogenic environments and socioeconomic position (SEP) across Dutch neighborhoods. Methods: Nationwide neighborhood-level data on health outcomes, obesogenic environmental exposures (food environment, walkability, drivability, bikeability, sports facilities), and SEP were combined for all inhabited Dutch administrative neighborhoods in 2016 (N = 12,420). Cluster analysis was used to identify distinct neighborhood profiles and descriptive statistics to characterize each cluster, with spatial patterns visualized using an interactive heatmap and principal component plots. Results: Five neighborhood clusters were identified. The ‘ Ecosyndemic cluster’ (N = 1,070 neighborhoods) exhibited the highest burden of obesity (17% [IQR 16;19]), chronic diseases (36% [IQR 33;38%]) and risk of anxiety/depression (55% [IQR 51;58]), unhealthy food environments and low SEP. In contrast, the ‘ Privileged cluster’ (N = 6,425) had more favorable health outcomes and living conditions, including lower obesity prevalence (12% [IQR 11;14]). The ‘ Psychosocial Vulnerability cluster’ (N = 991) was notable for elevated risk of anxiety/depression (47% [IQR 43;51]) combined with relatively low obesity (11% [IQR 8;12]). The ‘ Syndemic cluster’ (N = 1,836; obesity 15% [IQR 14;17]) and ‘ Towards Privileged cluster’ (N = 2,098; obesity 12% [IQR 10;13]) represented intermediate profiles. Conclusion: Obesity and related health issues frequently cluster with unfavorable environment and SEP at the neighborhood level. The ecosyndemic framework offers a novel approach for identifying high-risk areas and supports targeted, social and place-based interventions.
- 14 August 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (8) , e0354964
Open AccessAn ecosyndemic framework for understanding obesity: Spatial clustering of health, environmental and socioeconomic disadvantage in the Netherlands
Introduction: Obesity and related health conditions are unevenly distributed across neighborhoods, often co-occuring with multiple health challenges and socioeconomic disadvantages. Using an ecosyndemic framework, which integrates ecological and social dimensions that contribute to the clustering of health problems, this study examines how adverse obesity-related health outcomes spatially cluster in relation to obesogenic environments and socioeconomic position (SEP) across Dutch neighborhoods. Methods: Nationwide neighborhood-level data on health outcomes, obesogenic environmental exposures (food environment, walkability, drivability, bikeability, sports facilities), and SEP were combined for all inhabited Dutch administrative neighborhoods in 2016 (N = 12,420). Cluster analysis was used to identify distinct neighborhood profiles and descriptive statistics to characterize each cluster, with spatial patterns visualized using an interactive heatmap and principal component plots. Results: Five neighborhood clusters were identified. The ‘ Ecosyndemic cluster’ (N = 1,070 neighborhoods) exhibited the highest burden of obesity (17% [IQR 16;19]), chronic diseases (36% [IQR 33;38%]) and risk of anxiety/depression (55% [IQR 51;58]), unhealthy food environments and low SEP. In contrast, the ‘ Privileged cluster’ (N = 6,425) had more favorable health outcomes and living conditions, including lower obesity prevalence (12% [IQR 11;14]). The ‘ Psychosocial Vulnerability cluster’ (N = 991) was notable for elevated risk of anxiety/depression (47% [IQR 43;51]) combined with relatively low obesity (11% [IQR 8;12]). The ‘ Syndemic cluster’ (N = 1,836; obesity 15% [IQR 14;17]) and ‘ Towards Privileged cluster’ (N = 2,098; obesity 12% [IQR 10;13]) represented intermediate profiles. Conclusion: Obesity and related health issues frequently cluster with unfavorable environment and SEP at the neighborhood level. The ecosyndemic framework offers a novel approach for identifying high-risk areas and supports targeted, social and place-based interventions.
- Open Access
Clinical, environmental, and sociodemographic factors in ethnic differences in incidence of type 2 diabetes complications and mortality in a Dutch dynamic prospective primary care cohort: a DIAMANT study
Introduction: Ethnic minority populations are disproportionately affected by type 2 diabetes (T2D). We investigated ethnic differences in the risks of diabetes-related complications and mortality in the Netherlands, and identified clinical, sociodemographic and environmental determinants associated with these differences. Methods: We included 175,112 adults with T2D from the dynamic prospective primary care cohort DIAMANT. DIAMANT data were linked to national registries from Statistics Netherlands and GECCO, a database integrating geographic, environmental and contextual exposures. Ethnic differences in complications risks were estimated using Cox proportional hazards models. Potential mediating factors were explored using machine-learning-based variable selection and association decomposition approaches. Results: At baseline, mean age was 65.4 (SD 12.3) years, 46.6% were women and median T2D duration was 11.3 [IQR 7.2; 15.8] years. Substantial heterogeneity in complication risk was observed across ethnic groups compared with Dutch-origin individuals. Retinopathy risk was consistently higher across nearly all non-Dutch groups (HRs 1.37-2.37). For macrovascular complications, elevated risks were mainly observed among Surinamese and Turkish individuals, including heart failure (HR 1.30 and 1.46, respectively). In contrast, individuals of Indonesian and Moroccan origin showed similar or lower risk for most complications. Environmental exposures (e.g. air pollution, temperature) and sociodemographic factors (e.g. main benefit, household composition) accounted for a substantial attenuation of several observed associations. Discussion: Substantial ethnic differences exist in risks of T2D complications and mortality, which showed to be heterogeneous across outcomes and populations. Our findings suggest that a considerable proportion of these disparities is attributable to differences in environmental and sociodemographic context, highlighting the importance of interventions that take into account differences in environmental and socio-demographic context.
Open AccessClinical, environmental, and sociodemographic factors in ethnic differences in incidence of type 2 diabetes complications and mortality in a Dutch dynamic prospective primary care cohort: a DIAMANT study
Introduction: Ethnic minority populations are disproportionately affected by type 2 diabetes (T2D). We investigated ethnic differences in the risks of diabetes-related complications and mortality in the Netherlands, and identified clinical, sociodemographic and environmental determinants associated with these differences. Methods: We included 175,112 adults with T2D from the dynamic prospective primary care cohort DIAMANT. DIAMANT data were linked to national registries from Statistics Netherlands and GECCO, a database integrating geographic, environmental and contextual exposures. Ethnic differences in complications risks were estimated using Cox proportional hazards models. Potential mediating factors were explored using machine-learning-based variable selection and association decomposition approaches. Results: At baseline, mean age was 65.4 (SD 12.3) years, 46.6% were women and median T2D duration was 11.3 [IQR 7.2; 15.8] years. Substantial heterogeneity in complication risk was observed across ethnic groups compared with Dutch-origin individuals. Retinopathy risk was consistently higher across nearly all non-Dutch groups (HRs 1.37-2.37). For macrovascular complications, elevated risks were mainly observed among Surinamese and Turkish individuals, including heart failure (HR 1.30 and 1.46, respectively). In contrast, individuals of Indonesian and Moroccan origin showed similar or lower risk for most complications. Environmental exposures (e.g. air pollution, temperature) and sociodemographic factors (e.g. main benefit, household composition) accounted for a substantial attenuation of several observed associations. Discussion: Substantial ethnic differences exist in risks of T2D complications and mortality, which showed to be heterogeneous across outcomes and populations. Our findings suggest that a considerable proportion of these disparities is attributable to differences in environmental and sociodemographic context, highlighting the importance of interventions that take into account differences in environmental and socio-demographic context.
- Open Access
- 16 April 2026
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- p. 1-15
A double-blind randomised controlled trial assessing the effect of menaquinone producing probiotics on vitamin K status
This double-blinded randomised controlled trial investigated whether menaquinones (MK) producing probiotics for 12 weeks improve vitamin K status, compared with placebo in 50-75 years old with at least one cardiovascular risk factor. Twenty participants were randomised to either MK-producing probiotics (n = 10) or placebo (n = 10). Plasma dephosphorylated-uncarboxylated matrix gla protein (dp-ucMGP) concentrations were the primary study outcome and determined at baseline, six and twelve weeks by a chemiluminescent InaKtif MGP assay, and analysed by linear mixed models. Secondary outcomes included serum MK-7 and phylloquinone and stool MK-4 to MK-10 and phylloquinone, assessed by linear regression. Three participants dropped out (two placebo, one intervention). Compliance was high; median 98% [IQR 96-99] and 90% [IQR 74-96] sachets used in intervention vs placebo arm. At 6 weeks, dp-ucMGP was significantly lower in the intervention group (−75.69 [95%-CI −128.37; −22.92] pmol/l), but this difference diminished by 12 weeks (−38.63 [95%-CI −94.49; 16.14] pmol/l) due to a reduction in the placebo group. Overall, the mean dp-ucMGP change over 12 weeks favoured the intervention (−59.89 [95%-CI −110.7; −9.187] pmol/l). Statistically significant differences in secondary outcomes included higher serum MK-7, and faecal MK-6 and MK-7 concentrations in the probiotic vs placebo arm (e.g. 4.41 [95%-CI 2.17; 6.65] μ g/L for serum MK-7). No other secondary outcomes differed significantly. MK producing probiotics may enhance vitamin K status in older adults at elevated cardiovascular risk. Larger, longer-term studies are needed to assess functional outcomes. The Netherlands Trial Register: NTR7505, 27-09-2018.
- 16 April 2026
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- p. 1-15
Open AccessA double-blind randomised controlled trial assessing the effect of menaquinone producing probiotics on vitamin K status
This double-blinded randomised controlled trial investigated whether menaquinones (MK) producing probiotics for 12 weeks improve vitamin K status, compared with placebo in 50-75 years old with at least one cardiovascular risk factor. Twenty participants were randomised to either MK-producing probiotics (n = 10) or placebo (n = 10). Plasma dephosphorylated-uncarboxylated matrix gla protein (dp-ucMGP) concentrations were the primary study outcome and determined at baseline, six and twelve weeks by a chemiluminescent InaKtif MGP assay, and analysed by linear mixed models. Secondary outcomes included serum MK-7 and phylloquinone and stool MK-4 to MK-10 and phylloquinone, assessed by linear regression. Three participants dropped out (two placebo, one intervention). Compliance was high; median 98% [IQR 96-99] and 90% [IQR 74-96] sachets used in intervention vs placebo arm. At 6 weeks, dp-ucMGP was significantly lower in the intervention group (−75.69 [95%-CI −128.37; −22.92] pmol/l), but this difference diminished by 12 weeks (−38.63 [95%-CI −94.49; 16.14] pmol/l) due to a reduction in the placebo group. Overall, the mean dp-ucMGP change over 12 weeks favoured the intervention (−59.89 [95%-CI −110.7; −9.187] pmol/l). Statistically significant differences in secondary outcomes included higher serum MK-7, and faecal MK-6 and MK-7 concentrations in the probiotic vs placebo arm (e.g. 4.41 [95%-CI 2.17; 6.65] μ g/L for serum MK-7). No other secondary outcomes differed significantly. MK producing probiotics may enhance vitamin K status in older adults at elevated cardiovascular risk. Larger, longer-term studies are needed to assess functional outcomes. The Netherlands Trial Register: NTR7505, 27-09-2018.
- Open Access
- 20 November 2025
- Published by Elsevier in Environment International
- Vol. 206, 109914
Ethnic inequalities in physico-chemical, physical and social neighborhood exposures: An individual-level data analysis of 13,926,781 adults
- 20 November 2025
- Published by Elsevier in Environment International
- Vol. 206, 109914
Open AccessEthnic inequalities in physico-chemical, physical and social neighborhood exposures: An individual-level data analysis of 13,926,781 adults
- Open Access
Ethnic inequalities in physico-chemical, physical and social neighborhood exposures: An individual-level data analysis of 13,926,781 adults
Highlights: – Nation-wide study with data for nearly all adult Dutch inhabitants. – Ethnic minorities face higher physico-chemical exposures than Dutch-origin inhabitants. – Food & physical activity environments better for ethnic minorities than Dutch-origin. – Socio-economic characteristics less favorable for ethnic minorities than Dutch-origin. Introduction: Ethnic minority populations may be disproportionally affected by unhealthy environmental exposures, increasing health inequities. This study aims to identify whether residential neighborhood exposures differ between ethnic groups in the Netherlands. Methods: This cross-sectional study included all adult residents of the Netherlands registered in the national population register on 01/01/2022 (N=13,926,871). Exposure data (physico-chemical, food and physical environment, socio-economic characteristics, health and social well-being) were obtained from Statistics Netherlands, GECCO and the Dutch Health Monitor, and linked to individuals based on geocoded home addresses. Ethnicity was based on country of birth of individuals and their parents. Estimated marginal means were calculated and ethnic differences in exposure determined using multiple linear and logistic regression, adjusted for age and sex, stratified by socio-economic status (SES) and population density. Results: Compared to Dutch-origin, ethnic minority populations had less favorable physico-chemical exposures (e.g. 0.87µg/m 3 [95%-CI: 0.86;0.88] higher PM2.5 exposure for Moroccans in “high SES-high population density”). Conversely, the food and physical activity environment was more favorable for ethnic minorities (e.g. 1.82km/ha [95%-CI 1.80;1.83] higher bike path density among Turks in the “low SES-low population” density category). Socio-economic characteristics of the environment were generally less favorable for ethnic minorities (E.g. difference between Dutch Caribbeans and Dutch-origin −4.23% [95%-CI −4.35;-4.11] in “high income-high population density”. Ethnic differences in health and social well-being varied. Neighborhood-level smoking was most prevalent among ethnic minorities, while excessive drinking was most prevalent among Dutch-origin. Exposure to vandalism and (sexual)violence was lowest among Dutch-origin and highest among Dutch Caribbean, Moroccans, Turks and Surinamese. Conclusion: Physico-chemical exposure, socio-economic characteristics of the environment and safety from crime were less favorable among ethnic minority populations compared to Dutch-origin. The food and physical activity environment was more favorable for ethnic minorities. Ethnic inequalities were most pronounced among Moroccans, Turks, Surinamese and Dutch Caribbeans compared to Dutch-origin.
Open AccessEthnic inequalities in physico-chemical, physical and social neighborhood exposures: An individual-level data analysis of 13,926,781 adults
Highlights: – Nation-wide study with data for nearly all adult Dutch inhabitants. – Ethnic minorities face higher physico-chemical exposures than Dutch-origin inhabitants. – Food & physical activity environments better for ethnic minorities than Dutch-origin. – Socio-economic characteristics less favorable for ethnic minorities than Dutch-origin. Introduction: Ethnic minority populations may be disproportionally affected by unhealthy environmental exposures, increasing health inequities. This study aims to identify whether residential neighborhood exposures differ between ethnic groups in the Netherlands. Methods: This cross-sectional study included all adult residents of the Netherlands registered in the national population register on 01/01/2022 (N=13,926,871). Exposure data (physico-chemical, food and physical environment, socio-economic characteristics, health and social well-being) were obtained from Statistics Netherlands, GECCO and the Dutch Health Monitor, and linked to individuals based on geocoded home addresses. Ethnicity was based on country of birth of individuals and their parents. Estimated marginal means were calculated and ethnic differences in exposure determined using multiple linear and logistic regression, adjusted for age and sex, stratified by socio-economic status (SES) and population density. Results: Compared to Dutch-origin, ethnic minority populations had less favorable physico-chemical exposures (e.g. 0.87µg/m 3 [95%-CI: 0.86;0.88] higher PM2.5 exposure for Moroccans in “high SES-high population density”). Conversely, the food and physical activity environment was more favorable for ethnic minorities (e.g. 1.82km/ha [95%-CI 1.80;1.83] higher bike path density among Turks in the “low SES-low population” density category). Socio-economic characteristics of the environment were generally less favorable for ethnic minorities (E.g. difference between Dutch Caribbeans and Dutch-origin −4.23% [95%-CI −4.35;-4.11] in “high income-high population density”. Ethnic differences in health and social well-being varied. Neighborhood-level smoking was most prevalent among ethnic minorities, while excessive drinking was most prevalent among Dutch-origin. Exposure to vandalism and (sexual)violence was lowest among Dutch-origin and highest among Dutch Caribbean, Moroccans, Turks and Surinamese. Conclusion: Physico-chemical exposure, socio-economic characteristics of the environment and safety from crime were less favorable among ethnic minority populations compared to Dutch-origin. The food and physical activity environment was more favorable for ethnic minorities. Ethnic inequalities were most pronounced among Moroccans, Turks, Surinamese and Dutch Caribbeans compared to Dutch-origin.
- Open Access
- 7 November 2024
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 12 (6) , e004345
Type 2 diabetes complications in ethnic minority compared with European host populations: a systematic review and meta-analysis
This systematic review and meta-analysis aimed to quantify differences in type 2 diabetes (T2D) complications between ethnic minority populations and European host populations, in both cross-sectional and prospective studies. Following Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines, we searched multiple databases for studies (until July 1, 2024) with T2D complications as outcome. Studies were included if they compared ethnic minority populations to the host population and were conducted in Europe. T2D complications included mortality, macrovascular and microvascular complications and mental disorders. Risk of bias was assessed with the assessment tool for observational cohort and cross-sectional studies. Risk estimates were pooled using random effects models. From a total of 2901 references, 58 studies were included, comprising 805 to 1 230 410 individuals for the meta-analyzed complications. Compared with the host population, ethnic minority populations generally had a lower risk of all-cause mortality (RR 0.70 (95% CI 0.63; 0.77); I2=87%)) and macrovascular complications (RR 0.72 (95% CI 0.58; 0.88); I2=88%). South Asians, however, showed comparable risks for most macrovascular complications and a slighthly higher risk of major adverse cardiovascular events. Increased risks for microvascular complications, nephropathy and retinopathy were observed (eg, in prospective studies RR 1.50 (95% CI 1.14; 1.96); I2=86% for nephropathy). No ethnic differences were observed for mental disorders. Ethnic minority populations with T2D in Europe are generally at reduced risk of all-cause mortality and macrovascular complications, but at higher risk of nephropathy and retinopathy. Our findings may help to further identify high-risk populations and to develop guidelines and future interventions. PROSPERO registration number:PROSPERO 2022 CRD42022366854.
- 7 November 2024
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 12 (6) , e004345
Open AccessType 2 diabetes complications in ethnic minority compared with European host populations: a systematic review and meta-analysis
This systematic review and meta-analysis aimed to quantify differences in type 2 diabetes (T2D) complications between ethnic minority populations and European host populations, in both cross-sectional and prospective studies. Following Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines, we searched multiple databases for studies (until July 1, 2024) with T2D complications as outcome. Studies were included if they compared ethnic minority populations to the host population and were conducted in Europe. T2D complications included mortality, macrovascular and microvascular complications and mental disorders. Risk of bias was assessed with the assessment tool for observational cohort and cross-sectional studies. Risk estimates were pooled using random effects models. From a total of 2901 references, 58 studies were included, comprising 805 to 1 230 410 individuals for the meta-analyzed complications. Compared with the host population, ethnic minority populations generally had a lower risk of all-cause mortality (RR 0.70 (95% CI 0.63; 0.77); I2=87%)) and macrovascular complications (RR 0.72 (95% CI 0.58; 0.88); I2=88%). South Asians, however, showed comparable risks for most macrovascular complications and a slighthly higher risk of major adverse cardiovascular events. Increased risks for microvascular complications, nephropathy and retinopathy were observed (eg, in prospective studies RR 1.50 (95% CI 1.14; 1.96); I2=86% for nephropathy). No ethnic differences were observed for mental disorders. Ethnic minority populations with T2D in Europe are generally at reduced risk of all-cause mortality and macrovascular complications, but at higher risk of nephropathy and retinopathy. Our findings may help to further identify high-risk populations and to develop guidelines and future interventions. PROSPERO registration number:PROSPERO 2022 CRD42022366854.
- Open Access
- 18 July 2024
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 12 (4) , e004180-8
Plasma sphingolipids mediate the association between gut microbiome composition and type 2 diabetes risk in the HELIUS cohort: a case-cohort study
Introduction The association between the gut microbiome and incident type 2 diabetes (T2D) is potentially partly mediated through sphingolipids, however these possible mediating mechanisms have not been investigated. We examined whether sphingolipids mediate the association between gut microbiome and T2D, using data from the Healthy Life in an Urban Setting study. Research design and methods Participants were of Dutch or South-Asian Surinamese ethnicity, aged 18–70 years, and without T2D at baseline. A case-cohort design (subcohort n=176, cases incident T2D n=36) was used. The exposure was measured by 16S rRNA sequencing (gut microbiome) and mediator by targeted metabolomics (sphingolipids). Dimensionality reduction was achieved by principle component analysis and Shannon diversity. Cox regression and procrustes analyses were used to assess the association between gut microbiome and T2D and sphingolipids and T2D, and between gut microbiome and sphingolipids, respectively. Mediation was tested familywise using mediation analysis with permutation testing and Bonferroni correction. Results Our study confirmed associations between gut microbiome and T2D and sphingolipids and T2D. Additionally, we showed that the gut microbiome was associated with sphingolipids. The association between gut microbiome and T2D was partly mediated by a sphingolipid principal component, which represents a dominance of ceramide species over more complex sphingolipids (HR 1.17; 95% CI 1.08 to 1.28; proportional explained 48%), and by Shannon diversity (HR 0.97; 95% CI 0.95 to 0.99; proportional explained 24.8%). Conclusions These data suggest that sphingolipids mediate the association between microbiome and T2D risk. Future research is needed to confirm observed findings and elucidate causality on a molecular level.
- 18 July 2024
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 12 (4) , e004180-8
Open AccessPlasma sphingolipids mediate the association between gut microbiome composition and type 2 diabetes risk in the HELIUS cohort: a case-cohort study
Introduction The association between the gut microbiome and incident type 2 diabetes (T2D) is potentially partly mediated through sphingolipids, however these possible mediating mechanisms have not been investigated. We examined whether sphingolipids mediate the association between gut microbiome and T2D, using data from the Healthy Life in an Urban Setting study. Research design and methods Participants were of Dutch or South-Asian Surinamese ethnicity, aged 18–70 years, and without T2D at baseline. A case-cohort design (subcohort n=176, cases incident T2D n=36) was used. The exposure was measured by 16S rRNA sequencing (gut microbiome) and mediator by targeted metabolomics (sphingolipids). Dimensionality reduction was achieved by principle component analysis and Shannon diversity. Cox regression and procrustes analyses were used to assess the association between gut microbiome and T2D and sphingolipids and T2D, and between gut microbiome and sphingolipids, respectively. Mediation was tested familywise using mediation analysis with permutation testing and Bonferroni correction. Results Our study confirmed associations between gut microbiome and T2D and sphingolipids and T2D. Additionally, we showed that the gut microbiome was associated with sphingolipids. The association between gut microbiome and T2D was partly mediated by a sphingolipid principal component, which represents a dominance of ceramide species over more complex sphingolipids (HR 1.17; 95% CI 1.08 to 1.28; proportional explained 48%), and by Shannon diversity (HR 0.97; 95% CI 0.95 to 0.99; proportional explained 24.8%). Conclusions These data suggest that sphingolipids mediate the association between microbiome and T2D risk. Future research is needed to confirm observed findings and elucidate causality on a molecular level.
- Open Access
- 1 February 2024
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 26 (5) , 1706-1713
Branched‐chain amino acid levels are inversely associated with incident and prevalent chronic kidney disease in people with type 2 diabetes
Aim: To investigate the association of plasma metabolites with incident and prevalent chronic kidney disease (CKD) in people with type 2 diabetes and establish whether this association is causal. Materials and Methods: The Hoorn Diabetes Care System cohort is a large prospective cohort consisting of individuals with type 2 diabetes from the northwest part of the Netherlands. In this cohort we assessed the association of baseline plasma levels of 172 metabolites with incident (N total = 462/N case = 81) and prevalent (N total = 1247/N case = 120) CKD using logistic regression. Additionally, replication in the UK Biobank, body mass index (BMI) mediation and causality of the association with Mendelian randomization was performed. Results: Elevated levels of total and individual branched‐chain amino acids (BCAAs)—valine, leucine and isoleucine—were associated with an increased risk of incident CKD, but with reduced odds of prevalent CKD, where BMI was identified as an effect modifier. The observed inverse effects were replicated in the UK Biobank. Mendelian randomization analysis did not provide evidence for a causal relationship between BCAAs and prevalent CKD. Conclusions: Our study shows the intricate relationship between plasma BCAA levels and CKD in individuals with type 2 diabetes. While an association exists, its manifestation varies based on disease status and BMI, with no definitive evidence supporting a causal link between BCAAs and prevalent CKD.
- 1 February 2024
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 26 (5) , 1706-1713
Open AccessBranched‐chain amino acid levels are inversely associated with incident and prevalent chronic kidney disease in people with type 2 diabetes
Aim: To investigate the association of plasma metabolites with incident and prevalent chronic kidney disease (CKD) in people with type 2 diabetes and establish whether this association is causal. Materials and Methods: The Hoorn Diabetes Care System cohort is a large prospective cohort consisting of individuals with type 2 diabetes from the northwest part of the Netherlands. In this cohort we assessed the association of baseline plasma levels of 172 metabolites with incident (N total = 462/N case = 81) and prevalent (N total = 1247/N case = 120) CKD using logistic regression. Additionally, replication in the UK Biobank, body mass index (BMI) mediation and causality of the association with Mendelian randomization was performed. Results: Elevated levels of total and individual branched‐chain amino acids (BCAAs)—valine, leucine and isoleucine—were associated with an increased risk of incident CKD, but with reduced odds of prevalent CKD, where BMI was identified as an effect modifier. The observed inverse effects were replicated in the UK Biobank. Mendelian randomization analysis did not provide evidence for a causal relationship between BCAAs and prevalent CKD. Conclusions: Our study shows the intricate relationship between plasma BCAA levels and CKD in individuals with type 2 diabetes. While an association exists, its manifestation varies based on disease status and BMI, with no definitive evidence supporting a causal link between BCAAs and prevalent CKD.
- Open Access
- 25 August 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (8) , e0290261
The entero-endocrine response following a mixed-meal tolerance test with a non-nutritive pre-load in participants with pre-diabetes and type 2 diabetes: A crossover randomized controlled trial proof of concept study
This crossover randomized controlled trial (RCT) investigated differences in short-term entero-endocrine response to a mixed-meal tolerance test preceded by nutrient sensing between participants with pre-diabetes (pre-T2D) and type 2 diabetes (T2D). Additionally, differences in gut and oral microbiome composition between participants with a high and low entero-endocrine response were investigated. Ten participants with pre-T2D and ten with T2D underwent three test days with pre-loads consisting of either swallowing water (control), or rinsing with a non-nutritive sweetener solution, or swallowing the sweetener solution before a mixed-meal tolerance test. Blood glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), glucagon, glucose, insulin and peptide YY (PYY) were determined at t = -20, 0, 15, 30, 60, 120 and 240 minutes. The composition of the oral and gut microbiome at baseline were also determined. The entero-endocrine response differed by pre-loads, e.g. a lower PYY response after swallowing the non-nutritive sweetener (-3585.2pg/mL [95% CI: -6440.6; -729.8]; p = 0.01). But it also differed by T2D status, e.g. a higher glucose, glucagon and PYY response was found in participants with T2D, compared to those with pre-T2D. Evidence for associations between the oral and gut microbiome composition and the entero-endocrine response was limited. Still, the level of entero-endocrine response was associated with several oral microbiome measures. Higher oral anterior α-diversity was associated with a lower PYY response (e.g. Inverse Simpson index -1357pg/mL [95% CI -2378; -336; 1.24]), and higher oral posterior α-diversitywith a higher GIP response (e.g. Inverse Simpson index 6773pg/mL [95% CI 132; 13414]) in models adjusted for sex, age and T2D status. Non-nutritive pre-loads influence the entero-endocrine response to a mixed-meal, and this effect varies based on (pre-)T2D status. The entero-endocrine response is likely not associated with the gut microbiome, and there is limited evidence for association with the α-diversity of the oral microbiome composition. Trial register: Netherlands Trial Register NTR7212, accessible through International Clinical Trials Registry Platform: ICTRP Search Portal (who.int).
- 25 August 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (8) , e0290261
Open AccessThe entero-endocrine response following a mixed-meal tolerance test with a non-nutritive pre-load in participants with pre-diabetes and type 2 diabetes: A crossover randomized controlled trial proof of concept study
This crossover randomized controlled trial (RCT) investigated differences in short-term entero-endocrine response to a mixed-meal tolerance test preceded by nutrient sensing between participants with pre-diabetes (pre-T2D) and type 2 diabetes (T2D). Additionally, differences in gut and oral microbiome composition between participants with a high and low entero-endocrine response were investigated. Ten participants with pre-T2D and ten with T2D underwent three test days with pre-loads consisting of either swallowing water (control), or rinsing with a non-nutritive sweetener solution, or swallowing the sweetener solution before a mixed-meal tolerance test. Blood glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), glucagon, glucose, insulin and peptide YY (PYY) were determined at t = -20, 0, 15, 30, 60, 120 and 240 minutes. The composition of the oral and gut microbiome at baseline were also determined. The entero-endocrine response differed by pre-loads, e.g. a lower PYY response after swallowing the non-nutritive sweetener (-3585.2pg/mL [95% CI: -6440.6; -729.8]; p = 0.01). But it also differed by T2D status, e.g. a higher glucose, glucagon and PYY response was found in participants with T2D, compared to those with pre-T2D. Evidence for associations between the oral and gut microbiome composition and the entero-endocrine response was limited. Still, the level of entero-endocrine response was associated with several oral microbiome measures. Higher oral anterior α-diversity was associated with a lower PYY response (e.g. Inverse Simpson index -1357pg/mL [95% CI -2378; -336; 1.24]), and higher oral posterior α-diversitywith a higher GIP response (e.g. Inverse Simpson index 6773pg/mL [95% CI 132; 13414]) in models adjusted for sex, age and T2D status. Non-nutritive pre-loads influence the entero-endocrine response to a mixed-meal, and this effect varies based on (pre-)T2D status. The entero-endocrine response is likely not associated with the gut microbiome, and there is limited evidence for association with the α-diversity of the oral microbiome composition. Trial register: Netherlands Trial Register NTR7212, accessible through International Clinical Trials Registry Platform: ICTRP Search Portal (who.int).
- Open Access
- 6 September 2022
- Published by Springer Nature in Trials
- Vol. 23 (1) , 1-9
The iHealth-T2D study: a cluster randomised trial for the prevention of type 2 diabetes amongst South Asians with central obesity and prediabetes—a statistical analysis plan
Background: South Asians are at high risk of type 2 diabetes (T2D). Lifestyle modification is effective at preventing T2D amongst South Asians, but the approaches to screening and intervention are limited by high costs, poor scalability and thus low impact on T2D burden. An intensive family-based lifestyle modification programme for the prevention of T2D was developed. The aim of the iHealth-T2D trial is to compare the effectiveness of this programme with usual care.Methods: The iHealth-T2D trial is designed as a cluster randomised controlled trial (RCT) conducted at 120 sites across India, Pakistan, Sri Lanka and the UK. A total of 3682 South Asian men and women with age between 40 and 70 years without T2D but at elevated risk for T2D [defined by central obesity (waist circumference ≥ 95 cm in Sri Lanka or ≥ 100 cm in India, Pakistan and the UK) and/or prediabetes (HbA1c ≥ 6.0%)] were included in the trial. Here, we describe in detail the statistical analysis plan (SAP), which was finalised before outcomes were available to the investigators. The primary outcome will be evaluated after 3 years of follow-up after enrolment to the study and is defined as T2D incidence in the intervention arm compared to usual care. Secondary outcomes are evaluated both after 1 and 3 years of follow-up and include biochemical measurements, anthropometric measurements, behavioural components and treatment compliance.Discussion: The iHealth-T2D trial will provide evidence of whether an intensive family-based lifestyle modification programme for South Asians who are at high risk for T2D is effective in the prevention of T2D. The data from the trial will be analysed according to this pre-specified SAP.Ethics and dissemination: The trial was approved by the international review board of each participating study site. Study findings will be disseminated through peer-reviewed publications and in conference presentations.Trial registration: EudraCT2016–001,350-18. Registered on 14 April 2016. ClinicalTrials.govNCT02949739. Registered on 31 October 2016.
- 6 September 2022
- Published by Springer Nature in Trials
- Vol. 23 (1) , 1-9
Open AccessThe iHealth-T2D study: a cluster randomised trial for the prevention of type 2 diabetes amongst South Asians with central obesity and prediabetes—a statistical analysis plan
Background: South Asians are at high risk of type 2 diabetes (T2D). Lifestyle modification is effective at preventing T2D amongst South Asians, but the approaches to screening and intervention are limited by high costs, poor scalability and thus low impact on T2D burden. An intensive family-based lifestyle modification programme for the prevention of T2D was developed. The aim of the iHealth-T2D trial is to compare the effectiveness of this programme with usual care.Methods: The iHealth-T2D trial is designed as a cluster randomised controlled trial (RCT) conducted at 120 sites across India, Pakistan, Sri Lanka and the UK. A total of 3682 South Asian men and women with age between 40 and 70 years without T2D but at elevated risk for T2D [defined by central obesity (waist circumference ≥ 95 cm in Sri Lanka or ≥ 100 cm in India, Pakistan and the UK) and/or prediabetes (HbA1c ≥ 6.0%)] were included in the trial. Here, we describe in detail the statistical analysis plan (SAP), which was finalised before outcomes were available to the investigators. The primary outcome will be evaluated after 3 years of follow-up after enrolment to the study and is defined as T2D incidence in the intervention arm compared to usual care. Secondary outcomes are evaluated both after 1 and 3 years of follow-up and include biochemical measurements, anthropometric measurements, behavioural components and treatment compliance.Discussion: The iHealth-T2D trial will provide evidence of whether an intensive family-based lifestyle modification programme for South Asians who are at high risk for T2D is effective in the prevention of T2D. The data from the trial will be analysed according to this pre-specified SAP.Ethics and dissemination: The trial was approved by the international review board of each participating study site. Study findings will be disseminated through peer-reviewed publications and in conference presentations.Trial registration: EudraCT2016–001,350-18. Registered on 14 April 2016. ClinicalTrials.govNCT02949739. Registered on 31 October 2016.